Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in INMB — Inmune Bio, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,164
-$7,861 QoQ
Shares Held
2,555
-76.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 83 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. INMB ranks #339 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in INMB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,164 2,555
2026-03-31 $12,025 10,642
2025-12-31 $38,776 24,857
2025-09-30 $28,745 13,887
2025-06-30 $22,367 9,683
2025-03-31 $50,905 6,518
2024-12-31 $29,779 6,377
2024-09-30 $22,756 4,222
2024-06-30 $34,953 3,963
2024-03-31 $1,727 147
2023-12-31 $1,632 145
2023-09-30 $16,003 2,364
2023-06-30 $29,318 3,229
2023-03-31 $21,840 3,381
2022-12-31 $48,201 7,603
2022-09-30 $78,603 12,678
2022-06-30 $120,462 13,627
2022-03-31 $119,698 14,216
2021-12-31 $117,391 11,509
2021-09-30 $51,015 2,627
2021-06-30 $913 52
2021-03-31 $617 52
2020-12-31 $688 40
2020-09-30 $412 40
2020-06-30 $120 23
2020-03-31 $73 22